Specialty Pharmacy

Spinal muscular atrophy is the leading genetic cause of death in infants.

Earlier results of the FAST trial, which was launched in 2004, found that reducing the number of radiotherapy fractions to 5 was feasible and safe in the short term.

Patients with cancer diagnosed more than 24 months ago are at an increased risk of severe COVID-19.

Status reaffirms PTCE as the leader in continuing pharmacy education

In addition to its potential uses in cancer treatment, this novel drug delivery system could be used with magnetic resonance imaging or fluorescence imaging.

How a pharmacy performs with respect to specific measures can be associated with a DIR fee.

Pharmacists are central health care professionals in medication therapy management and play a crucial role in improving life quality outcomes among patients.

The International Society for Pharmaceutical Engineering (ISPE) released its newest guide to help pharmaceutical organizations achieve and maintain control in their critical utility systems.

Leung added that this is the first study to show the potential beneficial effects of ACE inhibitors and ARBs on colorectal cancer development, based on a large group of patients who were colorectal cancer-free at the beginning of the study.

The presence of ctDNA and CTCs in the plasma of the blood of women who have undergone chemotherapy prior to surgery for the treatment of triple-negative breast cancer (TNBC) are critical indicators in the prediction of disease recurrence and disease-free survival.

Mylan plans to launch adalimumab-fkjp in the United States in July 2023.

Since 2015, there has been an increase in the number of specialty pharmacies in the United States due to their potential of handling the complexities of cost and appropriate drug access and administration.

Tofersen proves safe in clinical trials in the treatment of amyotrophic lateral sclerosis.

Regardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.

According to new research published in Clinical and Translational Immunology, a new cancer vaccine is ready for human trials following its success in preclinical studies.

Regular testing for hepatitis C virus has proven more effective than targeted testing.

Pharmacy Times® interviewed Tim Safley, program director of the Accreditation Commission for Health Care (ACHC), and Jon Pritchett, program director of ACHC, on the value of specialty pharmacy and LTC accreditation for pharmacies.

The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience.

Early and frequent screenings for childhood cancer survivors could cut breast cancer mortality by well over half.

Pharmacy Times® interviewed Tim Safley and Jon Pritchett of ACHC on evaluating the opportunities for long-term care (LTC) pharmacies in relation to specialty pharmacy accreditation.

A potential correlation between processed food and breast cancer has been discovered.

Multiple pharmacies recently received letters from ESI stating that on behalf of TRICARE and the Defense Health Agency, ESI was recouping money for compound drug claims submitted in 2015.

According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.

Urothelial carcinoma accounts for approximately 90% of all bladder cancers and becomes increasingly challenging to treat as it spreads through the layers of the bladder wall.

The development and use of specialty pharmaceuticals have significantly affected global health care practices and costs.

According to a press release, this is the first single-agent, anti-PD-1 therapy approved in the first-line environment for this patient population.

Pharmacy Times® interviewed Cory Kidd, PhD, CEO and founder of Catalia Health, on the value of technology in innovating patient care in the field of specialty pharmacy.

Erlotinib taken with gemcitabine was approved by the FDA for locally advanced, inoperable, or metastatic pancreatic cancer in 2005.

A new study found disturbing evidence that black cancer survivors are more likely to face financial hardship on high deductible health plans than their white counterparts.

Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.